Bone Graft Substitutes Market 2027 Statistics – Size, Shares and Demand Reflecting Favourably on Industry Growth Across the Globe

Bone Graft Substitutes Market 2027 Statistics – Size, Shares and Demand Reflecting Favourably on Industry Growth Across the Globe

“Bone Graft Substitutes Market”
Bone Graft Substitutes Market is projected to grow at a CAGR of ~ 6.52 % during the forecast period 2018-2027. Bone Graft Substitute Market information: by type (autograft, demineralized bone matrix, synthetic bone grafts, bone morphogenetic protein, others), by application (spinal fusion, joint reconstruction, long bone, dental, foot & ankle, others) – Global forecast till 2027

The Global Bone Graft Substitute Market is expected to touch USD 5,031 million at a stellar 6.52% CAGR over the forecast period (2017-2027). Simply put, bone graft is an implantable material that helps in promoting bone healing, osseous reconstruction and bone formation owing to its osteoinductive, osteogenic and osteoconductive properties. Bone graft is used in spinal surgery, sports, trauma plastic and facial surgery. Besides it can be used for filling the voids during absence of bones and structural stability. It is a surgical method to replace a defected or missing bone using bone graft from the body of the patient, another person, animals or cadaver. Bone graft is also used to heal wounds, treat complex fracture and others.

To Get Sample Report visit https://www.marketresearchfuture.com/sample_request/1195

There are many factors that is driving the growth of the bone graft substitute market. Some of these factors as per the Market Research Future (MRFR) report include increasing incidence of musculoskeletal disorders, advancements in technology in the medical sector resulting in shift to allograft from autograft, development of the biocompatible synthetic bone grafts, rising demand for the dental bone grafts, key players laying emphasis on research and development activities both in bone grafts as well as its substitutes, increase in demand for orthopedic methods amid geriatric population, accessibility of advanced products in different sizes and shapes offering high osteoinductive and osteoconductive properties and shift to minimally invasive techniques. On the contrary, factors such as soaring cost of surgeries, ethical issues associated to bone grafting techniques, stringent regulatory pathway, unmet medical needs especially in low income countries, improper fixation, weak bonding, risk of graft rejection and patient safety owing to the danger of disease transmission in xenograft and allografts is likely to hamper the growth of the bone graft substitute market.

Industry Developments :

In August 2018, BoneSupport, a Scandinavian orthobiologics company, won Health Canada approval for Cerament G bone graft substitute.

In September 2018, Baxter International Inc., an American healthcare company, received FDA clearance for its Actifuse Flow bone graft substitute. It shall be used in orthopedic surgical procedures.

Industry News :

In March 2018, Dentsply Sirona, a dental solution company, announced the acquisition of over OraMetrix, a provider of innovative 3D technology solutions for orthodontic care. The acquisition is a remarkable step towards the advancement of dental bone graft procedure.

In August 2018, Scandinavian orthobiologics company Bone Support received approval from Health Canada for Cerament G bone graft substitute.

In September 2018, Baxter International Inc., an American healthcare company, announced the receipt of FDA clearance for Actifuse Flow bone graft substitute to be used in orthopedic surgical procedures.

In November 2018, Bio2 Technologies, an orthopedic company, has received approval from FDA for evaluation of its Vitrium bioactive glass as a cervical interbody fusion device. Vitrium is currently in use as a bone graft.

Key Players :

Leading players profiled in the bone graft substitute market include Institut Straumann AG, Zimmer Biomet, Stryker Corporation, Medtronic plc, Dentsply Sirona, BioHorizons IPH, Inc, Dentium Co., Ltd., and ACE Surgical Supply Company, Inc.

Feb 2019- Sirakoss Ltd received CE mark clearance for its Osteo, the bone graft substitute which is nanosynthetic in nature intended to augment the healing of patients and offer surgeons with an advanced bone fracture solution. Osteo has specially been designed for supporting the skeletal system post corrective surgery of any deformity condition or completing bone regeneration following a fracture. This bone graft material will help in filling gaps in the skeletal system and can be used on its own or in combination with allograft or autograft.

Segments :

Market Research Future report offers an all-inclusive segmental analysis of the bone graft substitute market on the basis type and application.

Based on type, it is segmented into bone morphogenetic protein, synthetic bone grafts, demineralized bone matrix, autograft and others.

Based on application, the bone graft substitute market is segmented into foot and ankle, dental, long bone, joint reconstruction, spinal fusion and others. Of these, spinal fusion is expected to have the maximum share in the market.

To Browse Complete Report visit https://www.marketresearchfuture.com/reports/bone-graft-substitutes-market-1195 

Regional Analysis :

Based on region, the bone graft substitute market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America will dominate the market and hold its position during the forecast period at a favorable 6.1% CAGR. It is owing to factors such as advancements in technology in healthcare, existence of key players and others. US has a highly developed healthcare sector which is another key reason that is driving the bone graft substitute market in this region. Europe grabs the second largest position and is anticipated to grow at a healthy 6.76% CAGR due to rising awareness regarding bone graft substitutes coupled with increasing healthcare expenditure. The bone graft substitute market in the APAC region is expected to grow at 6.85% CAGR over the forecast period. The existence of fast developing economies like India and China are greatly supporting the market growth. On the other hand, the bone graft substitute market in the Middle East and Africa is anticipated to have a steady growth owing to developments in the Gulf nations’ healthcare sector.

Some Brief Table of Contents of Report

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

TOC Continued…

To Get an Exclusive Discount on Report Visit https://www.marketresearchfuture.com/check-discount/1195

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/bone-graft-substitutes-market-1195